These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 18348690
1. Overexpression of human hydroxysteroid (17beta) dehydrogenase 2 induces disturbance in skeletal development in young male mice. Shen Z, Peng Z, Sun Y, Väänänen HK, Poutanen M. J Bone Miner Res; 2008 Aug; 23(8):1217-26. PubMed ID: 18348690 [Abstract] [Full Text] [Related]
2. Skeletal changes in transgenic male mice expressing human cytochrome p450 aromatase. Peng Z, Li X, Mäkelä S, Väänänen HK, Poutanen M. J Bone Miner Res; 2004 Aug; 19(8):1320-8. PubMed ID: 15231020 [Abstract] [Full Text] [Related]
3. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. Rosen CJ, Ackert-Bicknell CL, Adamo ML, Shultz KL, Rubin J, Donahue LR, Horton LG, Delahunty KM, Beamer WG, Sipos J, Clemmons D, Nelson T, Bouxsein ML, Horowitz M. Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029 [Abstract] [Full Text] [Related]
4. Chronic alcohol consumption during male rat adolescence impairs skeletal development through effects on osteoblast gene expression, bone mineral density, and bone strength. Wezeman FH, Emanuele MA, Emanuele NV, Moskal SF, Woods M, Suri M, Steiner J, LaPaglia N. Alcohol Clin Exp Res; 1999 Sep; 23(9):1534-42. PubMed ID: 10512321 [Abstract] [Full Text] [Related]
5. The thyroid hormone receptor beta-specific agonist GC-1 selectively affects the bone development of hypothyroid rats. Freitas FR, Capelo LP, O'Shea PJ, Jorgetti V, Moriscot AS, Scanlan TS, Williams GR, Zorn TM, Gouveia CH. J Bone Miner Res; 2005 Feb; 20(2):294-304. PubMed ID: 15647824 [Abstract] [Full Text] [Related]
7. Tamoxifen impairs both longitudinal and cortical bone growth in young male rats. Karimian E, Chagin AS, Gjerde J, Heino T, Lien EA, Ohlsson C, Sävendahl L. J Bone Miner Res; 2008 Aug; 23(8):1267-77. PubMed ID: 18348701 [Abstract] [Full Text] [Related]
8. Sexual dimorphism in cortical bone size and strength but not density is determined by independent and time-specific actions of sex steroids and IGF-1: evidence from pubertal mouse models. Callewaert F, Venken K, Kopchick JJ, Torcasio A, van Lenthe GH, Boonen S, Vanderschueren D. J Bone Miner Res; 2010 Mar; 25(3):617-26. PubMed ID: 19888832 [Abstract] [Full Text] [Related]
9. Alendronate administration and skeletal response during chronic alcohol intake in the adolescent male rat. Wezeman FH, Emanuele MA, Moskal SF, Steiner J, Lapaglia N. J Bone Miner Res; 2000 Oct; 15(10):2033-41. PubMed ID: 11028458 [Abstract] [Full Text] [Related]
10. Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling. Jiang J, Lichtler AC, Gronowicz GA, Adams DJ, Clark SH, Rosen CJ, Kream BE. Bone; 2006 Sep; 39(3):494-504. PubMed ID: 16644298 [Abstract] [Full Text] [Related]
11. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss. Wang L, Liu S, Quarles LD, Spurney RF. Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587 [Abstract] [Full Text] [Related]
12. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. Windahl SH, Vidal O, Andersson G, Gustafsson JA, Ohlsson C. J Clin Invest; 1999 Oct; 104(7):895-901. PubMed ID: 10510330 [Abstract] [Full Text] [Related]
13. Caloric restriction decreases cortical bone mass but spares trabecular bone in the mouse skeleton: implications for the regulation of bone mass by body weight. Hamrick MW, Ding KH, Ponnala S, Ferrari SL, Isales CM. J Bone Miner Res; 2008 Jun; 23(6):870-8. PubMed ID: 18435579 [Abstract] [Full Text] [Related]
14. Female estrogen receptor beta-/- mice are partially protected against age-related trabecular bone loss. Windahl SH, Hollberg K, Vidal O, Gustafsson JA, Ohlsson C, Andersson G. J Bone Miner Res; 2001 Aug; 16(8):1388-98. PubMed ID: 11499861 [Abstract] [Full Text] [Related]
15. Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats. Tivesten A, Movérare-Skrtic S, Chagin A, Venken K, Salmon P, Vanderschueren D, Sävendahl L, Holmäng A, Ohlsson C. J Bone Miner Res; 2004 Nov; 19(11):1833-9. PubMed ID: 15476584 [Abstract] [Full Text] [Related]
16. Paracrine overexpression of IGFBP-4 in osteoblasts of transgenic mice decreases bone turnover and causes global growth retardation. Zhang M, Faugere MC, Malluche H, Rosen CJ, Chernausek SD, Clemens TL. J Bone Miner Res; 2003 May; 18(5):836-43. PubMed ID: 12733722 [Abstract] [Full Text] [Related]
17. Growth without growth hormone receptor: estradiol is a major growth hormone-independent regulator of hepatic IGF-I synthesis. Venken K, Schuit F, Van Lommel L, Tsukamoto K, Kopchick JJ, Coschigano K, Ohlsson C, Movérare S, Boonen S, Bouillon R, Vanderschueren D. J Bone Miner Res; 2005 Dec; 20(12):2138-49. PubMed ID: 16294267 [Abstract] [Full Text] [Related]
18. Supraphysiological testosterone enanthate administration prevents bone loss and augments bone strength in gonadectomized male and female rats. Yarrow JF, Conover CF, Purandare AV, Bhakta AM, Zheng N, Conrad B, Altman MK, Franz SE, Wronski TJ, Borst SE. Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1213-22. PubMed ID: 18780767 [Abstract] [Full Text] [Related]
19. Bone and mineral metabolism in the androgen-resistant (testicular feminized) male rat. Vanderschueren D, Van Herck E, Suiker AM, Visser WJ, Schot LP, Chung K, Lucas RS, Einhorn TA, Bouillon R. J Bone Miner Res; 1993 Jul; 8(7):801-9. PubMed ID: 8352063 [Abstract] [Full Text] [Related]
20. Selective osteoblast overexpression of IGF-I in mice prevents low protein-induced deterioration of bone strength and material level properties. Brennan-Speranza TC, Rizzoli R, Kream BE, Rosen C, Ammann P. Bone; 2011 Nov; 49(5):1073-9. PubMed ID: 21840432 [Abstract] [Full Text] [Related] Page: [Next] [New Search]